Liminatus Pharma (LIMN) Operating Expenses (2024 - 2026)
Liminatus Pharma (LIMN) posted Operating Expenses of $1.1 million for Q1 2026, up 24.51% sequentially from $884211.0 in Q4 2025, and up 316.66% YoY from $264220.0 in Q1 2025.
Liminatus Pharma (LIMN) Operating Expenses (2024 - 2026) Analysis & Trends
Liminatus Pharma has reported Operating Expenses for 3 years, with the latest figure at $1.1 million in Q1 2026.
- Quarterly Operating Expenses rose 316.66% year-over-year to $1.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.8 million (up 101.97% YoY) and the FY2025 annual result came in at $3.0 million, down 10.88% from the prior year.
- Operating Expenses climbed to $1.1 million in Q1 2026 per LIMN's latest filing, from $884211.0 in the prior quarter.
- Over five years, Operating Expenses peaked at $1.1 million in Q2 2025 and troughed at $167077.0 in Q4 2024.
- A 3-year average of $711019.0 and a median of $792690.5 in 2025 frame the typical range for Operating Expenses.
- The widest YoY moves for Operating Expenses: up 429.22% in 2025, down 22.99% in 2025.
- Over 3 years, Operating Expenses stood at $167077.0 in 2024, then jumped by 429.22% to $884211.0 in 2025, then increased by 24.51% to $1.1 million in 2026.
- According to Business Quant data, Operating Expenses over the past three periods registered $1.1 million, $884211.0, and $701170.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 2.89 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 960.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 1.21 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 1.06 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 427.03 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 541.02 Mn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -784.57 Mn |
| 10 | Liminatus Pharma | 5.46 Mn | 5.46 Mn | - | 1.38 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.10 Mn |
| Dec 31, 2025 | 884,211.00 |
| Sep 30, 2025 | 701,170.00 |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 264,220.00 |
| Dec 31, 2024 | 167,077.00 |
| Sep 30, 2024 | 543,147.00 |
| Jun 30, 2024 | 909,218.00 |